CAMSBeijing, Beijing
Disclosures:
2689 - Early Results of a Phase II Trial of Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients (UNIQUE)
Monday, September 30, 20243:00 PM – 4:00 PM ET
2690 - Early Results of a Prospective Study of Preoperative Tumor-Bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early-Stage Breast Cancer
